Registration, Annual and Special Reporting
Home > Firm Summary
|
For a list of issuers (if any) that the firm has audited, or in whose audits the firm has played a substantial role, see Part IV of the firm's annual reports.
|
Annual and Special Reporting by the Firm
Auditor Reporting of Certain Audit Participants
Form | Filed Date | Issuer Name | Audit Report Date | Engagement Partner | |
Form AP
|
04/18/2023
|
HOOKIPA Pharma Inc.
|
03/15/2023
|
Mulas, Stefano Fiorenzo
|
|
Form AP
|
04/22/2022
|
HOOKIPA PHARMA INC.
|
03/24/2022
|
Mulas, Stefano Fiorenzo
|
|
Form AP/A
|
04/08/2022
|
HOOKIPA PHARMA INC.
|
02/25/2019
|
Rester, Alexandra -
|
|
Form AP
|
03/29/2019
|
HOOKIPA PHARMA INC.
|
02/25/2019
|
Rester, Alexandra -
|
|
Form AP/A
|
04/08/2022
|
HOOKIPA PHARMA INC.
|
03/18/2021
|
Mulas, Stefano Fiorenzo
|
|
Form AP
|
04/21/2021
|
HOOKIPA PHARMA INC.
|
03/18/2021
|
Mulas, Stefano Fiorenzo
|
|
Form AP/A
|
04/08/2022
|
HOOKIPA PHARMA INC.
|
02/25/2019
|
Rester, Alexandra .
|
|
Form AP
|
05/13/2019
|
HOOKIPA PHARMA INC.
|
02/25/2019
|
Rester, Alexandra .
|
|
Form AP/A
|
04/08/2022
|
HOOKIPA PHARMA INC.
|
03/19/2020
|
Rester, Alexandra -
|
|
Form AP
|
04/08/2020
|
HOOKIPA PHARMA INC.
|
03/19/2020
|
Rester, Alexandra -
|
|
Form AP
|
04/20/2017
|
Nabriva Therapeutics AG
|
03/24/2017
|
Rester, Alexandra -
|
|
|
Currently Subject to Board Determination Under the Holding Foreign Companies Accountable Act?
|